Research programme: anti-PDGFR alpha and beta monoclonal antibodies - Eli LillyAlternative Names: Anti-PDGFR monoclonal antibodies - Eli Lilly; PDGFRβ MAb - Eli Lilly
Latest Information Update: 27 Mar 2009
At a glance
- Originator ImClone Systems
- Developer Eli Lilly
- Class Monoclonal antibodies
- Mechanism of Action Platelet derived growth factor alpha receptor antagonists; Platelet-derived growth factor beta receptor antagonists; Platelet-derived growth factor inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours